International consensus statement on allergy and rhinology: rhinosinusitis 2021
…, R Sacks, RJ Schlosser, AR Sedaghat… - International forum of …, 2021 - Wiley Online Library
I. Executive Summary Background The 5 years since the publication of the first International
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICAR‐RS) has witnessed …
<? covid19?> Olfactory dysfunction and sinonasal symptomatology in COVID-19: prevalence, severity, timing, and associated characteristics
…, SJ Brockmeier, AR Sedaghat - … –Head and Neck …, 2020 - journals.sagepub.com
Objective Olfactory dysfunction (OD)—hyposmia or anosmia—is a symptom of coronavirus
disease 2019 (COVID-19), caused by the novel coronavirus, severe acute respiratory …
disease 2019 (COVID-19), caused by the novel coronavirus, severe acute respiratory …
Residual human immunodeficiency virus type 1 viremia in some patients on antiretroviral therapy is dominated by a small number of invariant clones rarely found in …
JR Bailey, AR Sedaghat, T Kieffer, T Brennan… - Journal of …, 2006 - Am Soc Microbiol
Antiretroviral therapy can reduce human immunodeficiency virus type 1 (HIV-1) viremia to
below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However…
below the detection limit of ultrasensitive clinical assays (50 copies of HIV-1 RNA/ml). However…
Resting CD4+ T Cells from Human Immunodeficiency Virus Type 1 (HIV-1)-Infected Individuals Carry Integrated HIV-1 Genomes within Actively Transcribed Host …
Y Han, K Lassen, D Monie, AR Sedaghat… - Journal of …, 2004 - Am Soc Microbiol
Resting CD4 + T-cell populations from human immunodeficiency virus type 1 (HIV-1)-infected
individuals include cells with integrated HIV-1 DNA. In individuals showing suppression of …
individuals include cells with integrated HIV-1 DNA. In individuals showing suppression of …
[HTML][HTML] Dose-response curve slope sets class-specific limits on inhibitory potential of anti-HIV drugs
L Shen, S Peterson, AR Sedaghat, MA McMahon… - Nature medicine, 2008 - nature.com
Highly active antiretroviral therapy (HAART) can control HIV-1 replication 1 , 2 , but suboptimal
treatment allows for the evolution of resistance and rebound viremia 3 , 4 , 5 , 6 , 7 , 8 . A …
treatment allows for the evolution of resistance and rebound viremia 3 , 4 , 5 , 6 , 7 , 8 . A …
International consensus statement on allergy and rhinology: Allergic rhinitis–2023
…, A Luong, K Rodriguez, AR Sedaghat… - International forum of …, 2023 - Wiley Online Library
Background In the 5 years that have passed since the publication of the 2018 International
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Consensus Statement on Allergy and Rhinology: Allergic Rhinitis (ICAR‐Allergic Rhinitis …
Sinonasal pathophysiology of SARS‐CoV‐2 and COVID‐19: A systematic review of the current evidence
…, JC Wang, MM Speth, AR Sedaghat - Laryngoscope …, 2020 - Wiley Online Library
Objective The ongoing pandemic of coronavirus disease (2019 coronavirus disease [COVID‐19]),
caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) …
caused by the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS‐CoV‐2) …
A mathematical model of metabolic insulin signaling pathways
AR Sedaghat, A Sherman… - American Journal of …, 2002 - journals.physiology.org
We develop a mathematical model that explicitly represents many of the known signaling
components mediating translocation of the insulin-responsive glucose transporter GLUT4 to …
components mediating translocation of the insulin-responsive glucose transporter GLUT4 to …
Assessing the wind energy potential locations in province of Semnan in Iran
M Mirhosseini, F Sharifi, A Sedaghat - Renewable and Sustainable Energy …, 2011 - Elsevier
In this study, the 3-h period measured wind speed data for years 2003–2007 at 10m, 30m
and 40m heights for one of the provinces of Iran. Semnan have been statistically analyzed to …
and 40m heights for one of the provinces of Iran. Semnan have been statistically analyzed to …
Understanding the minimal clinically important difference (MCID) of patient-reported outcome measures
AR Sedaghat - Otolaryngology–Head and Neck Surgery, 2019 - journals.sagepub.com
Objective The minimal clinically important difference (MCID) of a patient-reported outcome
measure (PROM) represents a threshold value of change in PROM score deemed to have an …
measure (PROM) represents a threshold value of change in PROM score deemed to have an …
